Page last updated: 2024-08-24

fluorodeoxyglucose f18 and Mast-Cell Sarcoma

fluorodeoxyglucose f18 has been researched along with Mast-Cell Sarcoma in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chaise, C; Copie-Bergman, C; Delfau-Larue, MH; Farcet, JP; Itti, E; Meignan, M; Molinier-Frenkel, V; Petegnief, Y; Talbot, JN; Wirquin, E1

Other Studies

1 other study(ies) available for fluorodeoxyglucose f18 and Mast-Cell Sarcoma

ArticleYear
[F-18]-Fluoro-2-deoxy-D: -glucose positron emission tomography as a tool for early detection of immunotherapy response in a murine B cell lymphoma model.
    Cancer immunology, immunotherapy : CII, 2007, Volume: 56, Issue:8

    Topics: Animals; Cancer Vaccines; Cell Line, Tumor; Early Diagnosis; Female; Fluorodeoxyglucose F18; Imaging, Three-Dimensional; Immunocompetence; Immunotherapy, Active; Injections, Intravenous; Liver; Lymph Nodes; Lymphoma, B-Cell; Mast-Cell Sarcoma; Mice; Mice, Inbred BALB C; Neoplasm Transplantation; Positron-Emission Tomography; Radiopharmaceuticals; Spleen; Tail

2007